U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557407) titled 'A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects' on April 22.
Brief Summary: The study aims to evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of [14C]HRS-1780 following an oral single dose in healthy adult male participants.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Diseases
Intervention:
DRUG: [14C]HRS-1780
[14C]HRS-1780, oral.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....